Investors are perpetually on the lookout for factors that can sway stock prices. One significant influencer that frequently triggers price fluctuations is news. Positive news can possess the power to propel stocks to new heights.
Let’s dive into a brief overview of four stocks that have recently taken the spotlight.
Ameritek Ventures Inc. (OTC:ATVK) is an emerging technology company that is focused on leading-edge industries like blockchain cloud software, robotic technology, and artificial intelligence. One of the more important subsidiary units of Ameritek Ventures Inc. is Augmum, which is involved in bringing about the integration of machine learning and augmented reality.
The innovative work from the subsidiary helps boost the control of robotic arms through the deployment of specialized gloves as well as glasses. The company believes that the technology could potentially help in the streamlining of a number of industries through improvements in precision and the automation of tasks.
The worldwide robotic technology market is expected to grow from $72 billion in 2022 to as much as $283 billion in 2032. Ameritek Ventures is in a position to cash in on the projected growth in the sector.
The company has been experiencing positive momentum in its chosen market as one of the leading software and hardware product providers to governments, businesses, and organizations. Ameritek Ventures offers its products through a range of subsidiary units, which specialize in particular sectors.
For instance, one of its subsidiaries, FlexFridge, helps it boost its presence in the medical field with FlexFridge, its flagship product, a portable smart mini fridge for medical use. Another subsidiary of Ameritek Ventures is DittoMask, which is helping the company establish its presence in the sports industry.
The subsidiary is involved in the development of customized masks that offer long-lasting protection against pollen, dust, smoke, and small particles. The masks have continued to clock strong demand from people who lead active lifestyles, and that includes athletes as well as those involved in outdoor activities.
On September 7, the company made a momentous announcement after it revealed that it had filed a patent application for its robotic arm technology. The company’s subsidiary unit is looking to create a platform dedicated to healthcare, the military, and companies so that robotic arm technology can be accessed remotely.
Remote access would help in controlling environments at a distance if there is a critical need for medical assistance. For instance, the technology from Augment would help army doctors view and interact with patients who may be stuck on the front lines.
“We are preparing the robotic arm technology for the market; it has been under development for the past 4 years,” said Shaun Passley, Ph.D., CEO of Ameritek Ventures, Inc. “Robotic Arm Technology works with our HailOas glasses to offer an all-in-one solution for remote environmental interaction.”
American Battery Technology Company (OTC:ABML) is an integrated critical battery materials company involved in the commercialization of both its primary mineral manufacturing technologies and secondary mineral lithium-ion battery recycling technologies. American Battery Technology Company enjoys a unique position in the overall market since it is positioned to supply low environmental impact and domestically sourced battery metals at lower costs through its three business divisions.
The three different divisions of the company are primary battery metal extraction technologies, primary resource development, and lithium-ion battery recycling. On September 11, the company’s Chief Executive Officer and Chief Technology Officer, Ryan Melsert, issued a letter to the shareholders. In the letter, it was revealed that the company had been successful in closing another fiscal year. The letter then went on to enumerate the progress that had been made in the previous year and some of the important steps that had been taken.
It was revealed that in the past year, American Battery Technology had acquired a ready-to-move plant in McCarran, Nevada. The company had acquired the plant for the purpose of implementing its unique, internally developed battery recycling process. It was also revealed that over the past two years, the company has been working on the development and exploration of its Tonopah Flats Lithium Project. In 2023, the company published its Inferred Resource Report, which had been audited by a third party.
The report concluded that it was one of the biggest known lithium resources in the United States. In the letter, it was noted that the company wished to further improve and expand the classification of the resources. Hence, it started a third drilling program in the summer of 2023.
Therapeutic Solutions International Inc. (OTC:TSOI) is an innovative company that is involved in immune modulation meant for treating a range of specific diseases. On September 11, Therapeutic Solutions International Inc. hit the headlines after it announced that it had managed to develop a new therapeutic approach for treating frontotemporal dementia.
The company revealed that it achieved that through the combination of activation of endogenous anti-inflammatory cells found in the nervous system with regenerative cell intervention in stem cell therapy form and molecules that have the capacity to activate endogenous stem cells in the patient. The company also revealed that a patent application had also been filed for the therapy. More importantly, the preliminary data from the therapy in animal testing had also been positive. Therapeutic Solutions International noted that it was planning to make the therapy available to patients with ‘no option’.
The Chief Medical Officer of Therapeutic Solutions International, Dr. James Veltmeyer, spoke about the developments as well. He revealed that frontotemporal dementia was a combination of different conditions, and the company had managed to come up with a diagnostic criterion. It had been based on the cellular, biochemical, and genetic characteristics of the patient.
Through the use of the above-mentioned factors and benchmarks, the company came up with a customized cocktail. The President and Chief Executive Officer of Therapeutic Solutions International, Timothy G. Dixon, described the company as an incubator and ‘therapeutic accelerator’. He called frontotemporal dementia ‘a terrifying condition’ that did not have any treatments available that could modify its effects. However, he noted that, as a company, Therapeutic Solutions had gone outside the box and on a totally different tangent to come up with a potential cure for the condition.
iQSTEL Inc. (OTC:IQST) is a United States-based multinational company that is publicly listed and is also preparing for an uplisting to NASDAQ in the 2023 financial year. In 2023, iQSTEL Inc. projected revenues of $120 million. On September 6, the company announced that, as per unaudited accounting, it managed to clock revenues in excess of $13 million for both the months of July and August this year.
In the first six months of the year, the company reported revenues to the tune of as much as $57.5 million, and the latest unaudited figures took its revenues up until the end of August to as much as $83 million. However, that figure is based on unaudited accounting. The $13 million in monthly revenues put iQSTEL on track to hit in excess of $130 million in annual revenues. That would smash the company’s own projection of $120 million in terms of annual revenues.
The Chief Executive Officer of the company, Leandro Iglesias, spoke about the latest development as well. He noted that everyone at the company was pleased with the fact that it was ahead of schedule in terms of its end-of-year revenue targets. He went on to note that the company was expecting annual revenues to exceed its initial forecast of $120 million.
Iglesias added that the company’s plans to increase operating income from telecom services were also progressing as intended. He stated that the company would continue to work on the expansion of its operations so as to boost its telecom business. He noted that it could lead to higher revenues and higher margins.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Ameritek Ventures Inc. to assist in the production and distribution of content. ‘CGR’ is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content.